Is ATHA A Good Stock To Buy According To Hedge Funds?
A whopping number of 13F filings filed with U.S.
Athira Pharma Inc. (ATHA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 540,296 | $2,236,825 | 0.06% | |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 149,279 | $618,015 | 0.62% | |
| 3. | Tang Capital Management Kevin C. Tang | 59,998 | $248,392 | 0.01% | |
| 4. | Renaissance Technologies Jim Simons | 51,924 | $214,965 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 33,987 | $140,706 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.42 | 27,400 | $66,179.22 | 80,715 | 2024-06-24 | Filing | |
| $2.26 | 15,000 | $33,871.50 | 53,315 | 2024-06-21 | Filing | |
| $2.38 | 163,954 | $390,210.52 | 5,402,964 | 2023-12-29 | Filing | |
| $2.44 | 409,598 | $999,419.12 | 5,239,010 | 2023-12-28 | Filing | |
| $2.28 | 32,134 | $73,265.52 | 4,829,412 | 2023-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.88 | 1,644 | $11,310.72 | 10,189 | 2026-01-02 | Filing | |
| $6.88 | 2,586 | $17,791.68 | 40,828 | 2026-01-02 | Filing | |
| $6.88 | 297 | $2,043.36 | 12,857 | 2026-01-02 | Filing | |
| $6.88 | 876 | $6,026.88 | 20,681 | 2026-01-02 | Filing | |
| $6.88 | 876 | $6,026.88 | 13,978 | 2026-01-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 153,789 | $1,164,183 | 0% | |
| 2. | 3,388 | $25,647 | 0% | |
| 3. | 200 | $1,514 | 0% | |
| 4. | 81 | $613 | 0% |
News See All
